Actinium Pharmaceuticals (NYSE:ATNM) Earns Buy Rating from HC Wainwright
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $4.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 230.58% from the company’s current price. Separately, Stephens […]
Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. They currently have a $4.00 price objective on the stock. HC Wainwright’s target price points to a potential upside of 230.58% from the company’s current price. Separately, Stephens […]
